Skip to content
lifestyle.thepointnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CARsgen Therapeutics
Results of CARsgen’s Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026
October 25, 2026
CARsgen Therapeutics Announces 2026 Interim Results
August 20, 2026
CARsgen Therapeutics Announces 2026 Interim Results
August 20, 2026
CARsgen Announces Approval of Satri-cel, the World’s First CAR T-Cell Therapy Product for Solid Tumors
June 22, 2026
CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026
June 14, 2026
Long-term Follow-up Results of CARsgen’s Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting
May 31, 2026